Yellow Medicine of Nature- The future Chartbuster Protoberberine Antivirals
Article Sidebar
-
Angiotensin-Converting Enzyme, Antiviral, Berberine, Isoquinoline, Medicinal plants, Protoberberine
Abstract
Emerging viral diseases are one of the principal threat towards the plants, animals and humans. Viruses are fast evolving, resulting in reduced effectiveness of existing drugs and vaccines. At this juncture, the importance of traditional medicine, as well as medicinal plant active principles, occupies central attention of researchers across the world. Protoberberine alkaloids, an essential group of isoquinoline family of alkaloids, exhibit properties were affecting the life cycle of DNA and RNA viruses. However, from this protoberberine group, only berberine alkaloid has been studied in detail for its mechanism of action. Berberine is useful both in the case of enveloped and non-enveloped viruses. Berberine inhibits viral life cycle by modulating NF-kB signalling, targeting viral glycoproteins and downregulation of MEK-ERK signalling. Apart from this, berberine also inhibits ACE. All protoberberine alkaloids share a characteristic protoberberine skeleton. The protoberberine containing botanicals also exhibited antiviral properties. Therefore protoberberine alkaloids and protoberberine containing botanicals are interesting to experiment in detail for their antiviral properties and mechanism of action in emerging viral diseases of plants, animals and humans.
Full text article
References
Balmeh, N., Mahmoudi, S., Mohammadi, N., Karabedianhajiabadi, A. 2020. Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV- 2 and its related receptors. Informatics in Medicine Unlocked, 20:100407–100407.
Blasko, G., Murugesan, N., Freyer, A. J., Shamma, M., Ansari, A. A., ur Rahman, A. 1982. Karachine: an unusual protoberberine alkaloid. Journal of the American Chemical Society, 104(7):2039–2041.
Byler, K. G., Collins, J. T., Ogungbe, I. V., Setzer, W. N. 2016. Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation. Computational Biology and Chemistry, 64:163–184.
Dipasquale, R. 2010. Yellow medicine: The berberine alkaloid plants. Botanical Medicine, Cardiopulmonary Medicine, Naturopathic News.
Gellert, E., Rudzats, R. 1972. The alkaloids of Schefferomitra subaequalis (Anonaceae). Australian Journal of Chemistry, 25(11):2477–2477.
Gong, J., Shen, X., Chen, C., Qiu, H., Yang, R. 2011. Down-regulation of HIV-1 infection by inhibition of the MAPK signalling pathway. Virologica Sinica, 26(2):114–122.
Gunatilaka, A. A. L. 1998. Chapter 1: Alkaloids from Srilankan Flora. Alkaloids: Chemistry and Biology, 52:1–101.
Hung, T. C., Jassey, A., Liu, C. H., Lin, C. J., Lin, C. C., Wong, S. H., Wang, J. Y., Yen, M. H., Lin, L. T. 2019. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein. Phytomedicine, 53:62–69.
Jia, F., Zou, G., Fan, J., Yuan, Z. 2010. Identification of palmatine as an inhibitor of West Nile virus. Archives of Virology, 155(8):1325–1329.
Kang, D. G., Sohn, E. J., Kwon, E. K., Han, J. H., Oh, H., Lee, H. S. 2002. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascular Pharmacology, 39(6):281–286.
Khan, M. Y., Kumar, V. 2019. Mechanism & inhibition kinetics of bioassay-guided fractions of Indian medicinal plants and foods as ACE inhibitors. Journal of Traditional and Complementary Medicine, 9(1):73–84.
Maddi, R., Kandula, V. L., Vallepu, B., Navuluri, H., Kollu, H. 2018. Preliminary Phytochemical Analysis and Invitro Antiviral Activity of Ethanolic extract of Whole plant of Tinospora cordifolia (Thunb.) Miers against Hepatitis-A Virus. Inter- national Journal of Scientific Research in Biological Sciences, 5(3):51–55.
Mirza, M. U., Ghori, N. I. N.-U.-H., Adil, A. R., Manzoor, S. 2015. Pharmacoinformatics approach for investigation of alternative potential hepatitis C virus non-structural protein 5B inhibitors. Drug design, development and therapy, 9:1825–1841.
Ng, T. B., Huang, B., Fong, W. P., Yeung, H. W. 1997. Anti-human immunodeficiency virus (anti- HIV) natural products with special emphasis on HIV reverse transcriptase inhibitors. Life Sciences, 61(10):933–949.
Orhan, I., Özçelik, B., Karaoğlu, T., Şener, B. 2007. Antiviral and Antimicrobial Profiles of Selected Isoquinoline Alkaloids from Fumaria and Corydalis Species. Zeitschrift für Naturforschung C, 62(1-2):19–26.
Purthvish, R., Gopinatha, S. M. 2018. Antiviral prospective of Tinospora cordifolia on HSV-1. Int. J. Curr. Microbiol. App. Sci, 7(1):3617–3624.
Qing, Z. X., Yang, P., Tang, Q., Cheng, P., Liu, X. B., Zheng, Y. J., Zeng, G, J. 2017. Isoquinoline alkaloids and their antiviral, antibacterial, and antifungal activities and structure-activity relationship. Cur- rent Organic Chemistry, 21(18):1920–1934.
Shamma, M., Dudock, B. S. 1968. Thalictrum Alkaloids V. Isolation. Journal of Pharmaceutical Sciences, 57(2):262–269.
Song, S., Qiu, M., Chu, Y., Chen, D., Wang, X., Su, A., Wu, Z. 2014. Downregulation of Cellular c-Jun N- Terminal Protein Kinase and NF-κB Activation by Berberine May Result in Inhibition of Herpes Sim- plex Virus Replication. Antimicrobial Agents and Chemotherapy, 58(9):5068–5078.
Varghese, F. S., Thaa, B., Amrun, S. N., Simarmata, D., Rausalu, K., Nyman, T. A., Merits, A., McInerney, G. M., Ng, L. F. P., Ahola, T. 2016. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus- Induced Mitogen-Activated Protein Kinase Signaling. Journal of Virology, 90(21):9743–9757.
Wang, H., Li, K., Ma, L., Wu, S., Hu, J., Yan, H., Li, Y. 2017. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signalling pathway and autophagy. Virology journal, 14(1):1–8.
Warowicka, A., Nawrot, R., Goździcka-Józefiak, A. 2020. Antiviral activity of berberine. Archives of Virology, 165(9):1935–1945.
Warowicka, A., Popenda, Ł., zyna Bartkowiak, G., Musidlak, O., Litowczenko-Cybulska, J., Kuźma, D., Nawrot, R., Jurga, S., Goździcka-Józefiak, A. 2019. Protoberberine compounds extracted from Chelidonium majus L. as novel natural photosensitizers for cancer therapy. Phytomedicine, 64:152919– 152919.
Wu, Y., Li, J. Q., Kim, Y. J., Wu, J., Wang, Q., Hao, Y. 2011. In vivo and in vitro antiviral effects of berberine on influenza virus. Chinese journal of integrative medicine, 17(6):444–452.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.